Inhibition of lipopolysaccharide‐induced cyclooxygenase‐2, tumor necrosis factor‐α and [Ca²⁺]_i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195

This publication has 28 references indexed in Scilit:

• Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK 11195) on some mononuclear phagocyte functions
  Biochemical Pharmacology, 2000
• PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor, Facilitates the Induction of Apoptosis and Reverses Bcl-2-Mediated Cytoprotection
  Experimental Cell Research, 1998
• Inflammatory Mechanisms of Alzheimer’s Disease
  Published by Springer Nature ,1998
• PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia
  Journal of Neurocytology, 1997
• PERIPHERAL ADMINISTRATION OF LIPOPOLYSACCHARIDE INDUCES ACTIVATION OF MICROGLIAL CELLS IN RAT BRAIN
  Neurochemistry International, 1996
• Bacterial endotoxin induces [Ca²⁺]i transients and changes the organization of actin in microglia
  Glia, 1994
• Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands.
  Proceedings of the National Academy of Sciences, 1993
• Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells
  Life Sciences, 1993
• Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
  Proceedings of the National Academy of Sciences, 1992
• SK&F 96365, a novel inhibitor of receptor-mediated calcium entry
  Biochemical Journal, 1990